Developmental and temporal changes in petunia petal transcriptome reveal scent-repressing plant-specific RING–kinase–WD40 protein by Ekaterina Shor, Oded Skaliter, Elad Sharon, Elad Sharon, Yaarit Kitsberg, Dominika Bednarczyk, Shane Kerzner, Danny Vainstein, Yuval Tabach, Alexander Vainstein

Get full text

Co-evolution based machine-learning for predicting functional interactions between human genes by Doron Stupp, Elad Sharon, Idit Bloch, Marinka Zitnik, Or Zuk, Yuval Tabach

Get full text

644 Ocular adverse events associated with programmed death-1 and programmed death ligand-1 immunotherapy by James Murray, Howard Streicher, Elad Sharon, Helen Chen, LeAnne Young, Shanda Finnigan, H Nida Sen

ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic by Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, Alexander Vainstein, Yuval Tabach

Get full text

Incidence and survival of rare cancers in the US and Europe by Laura Botta, Gemma Gatta, Annalisa Trama, Alice Bernasconi, Elad Sharon, Riccardo Capocaccia, Angela B. Mariotto, the RARECAREnet working group

Get full text

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development by Jeffrey Sosman, Elad Sharon, Theresa LaVallee, Hussein A Tawbi, Ryan J Sullivan, Harriet M Kluger, Naiyer A Rizvi, David Feltquate

Get full text

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors by Harriet Kluger, Omid Hamid, Roberta Zappasodi, Michael Hurwitz, Hussein Tawbi, Elad Sharon, Theresa LaVallee, Rebecca A Moss, Justin F Gainor, J Carl Barrett, Ryan J Sullivan

Get full text

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement by Apostolia M. Tsimberidou, Laura A. Levit, Richard L. Schilsky, Steven D. Averbuch, Daniel Chen, John M. Kirkwood, Lisa M. McShane, Elad Sharon, Kathryn F. Mileham, Michael A. Postow

Get full text

Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs by Tian Zhang, Patrick M Forde, Elad Sharon, Scot Ebbinghaus, Michael B Atkins, Mark Stewart, Ryan J Sullivan, Elizabeth Barksdale, Wendy Selig, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert

Get full text

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors by Howard Streicher, Elad Sharon, Mariano Severgnini, Michael Manos, Anita Giobbie-Hurder, F Stephen Hodi, Andrew S Brohl, Philippe L Bedard, Kevin Tyan, Scott Rodig, Osama E Rahma, Daniel J Renouf, Emma Hathaway, Rachel Cunningham

Get full text

Using multi-scale genomics to associate poorly annotated genes with rare diseases by Christina Canavati, Dana Sherill-Rofe, Lara Kamal, Idit Bloch, Fouad Zahdeh, Elad Sharon, Batel Terespolsky, Islam Abu Allan, Grace Rabie, Mariana Kawas, Hanin Kassem, Karen B. Avraham, Paul Renbaum, Ephrat Levy-Lahad, Moien Kanaan, Yuval Tabach

Get full text

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study by Xuemei Wang, Jessica Harris, John Thompson, Elad Sharon, Yinghong Wang, Aline Charabaty, Marc S Ernstoff, Jennifer McQuade, Michel Obeid, Stephen Hanauer, Amishi Shah, Fangwen Zou, Isabella C Glitza Oliva, David Faleck, Anusha Thomas, Deepika Satish, David M Richards

Get full text

P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING... by Jan Bewersdorf, Rory M. Shallis, Elad Sharon, Anne Caldwell, Wei Wei, Abdulraheem Yacoub, Yazan Madanat, Joshua Zeidner, Jessica Altman, Olatoyosi Odenike, Swaroopa Yerrabothala, Tibor Kovacsovics, Nikolai Podoltsev, Stephanie Halene, Richard Little, Richard Pierkarz, Steven Gore, Tae Kon Kim, Amer M. Zeidan

Get full text

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology by Laura C Cappelli, Maria E Suarez-Almazor, Michelle Turner, Stephane Champiat, Caroline Robert, Julie R Brahmer, Jarushka Naidoo, Jeffrey Weber, Joanne Riemer, Elad Sharon, Michael B Atkins, M Catherine Pietanza, Karthik Suresh, Catherine Murphy, Javid Moslehi, David Feltquate, Lee M Krug

Get full text

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in... by Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Edward Mayerson, Melissa Plets, Charles Blanke, Ashish Sangal, Benjamin Powers, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Mark Agulnik, G Thomas Budd, Michael J Wagner, Sandip P Patel, Chris Ryan, Adrienne I Victor, Kirsten M Leu

Get full text

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review by Benjamin P. Geisler, Lara Zahabi, Adam Edward Lang, Naomi Eastwood, Elaine Tennant, Ljiljana Lukic, Elad Sharon, Hai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, Ahmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, Debbie Teodorescu, Ludwig Christian Hinske, Dennis L. Sun, Farrin A. Manian, Adam G. Dunn

Get full text

Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocol... by Elad, Sharon, Barasch, Andrei, Genot, Marie-Thérèse, Lansaat, Liset, van der Brink, Ron, Arnabat-Dominguez, Josep, van der Molen, Lisette, Jacobi, Irene, van Diessen, Judi, de Lange, Jan, Bensadoun, René-Jean, Zecha, Judith A. E. M., Raber-Durlacher, Judith E., Nair, Raj G., Epstein, Joel B., Migliorati, Cesar A., Milstein, Dan M. J., Smeele, Ludi E., Schubert, Mark M., Hamblin, Michael R

Get full text

Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety... by Elad, Sharon, Barasch, Andrei, Genot, Marie-Thérèse, Lansaat, Liset, van der Brink, Ron, Arnabat-Dominguez, Josep, van der Molen, Lisette, Jacobi, Irene, van Diessen, Judi, de Lange, Jan, Bensadoun, René-Jean, Zecha, Judith A. E. M., Raber-Durlacher, Judith E., Nair, Raj G., Epstein, Joel B., Sonis, Stephen T., Migliorati, Cesar A., Milstein, Dan M. J., Smeele, Ludi E., Schubert, Mark M., Hamblin, Michael R

Get full text

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyResearch in context by Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V. Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir A. Toor, Stephanie Waldvogel, Lee M. Greenberger, Jeffery J. Auletta, Mary M. Horowitz, Marcie L. Riches, Miguel-Angel Perales

Get full text

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 by Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E. Claire Dees, Cesar A. Santa-Maria, Roisin M. Connolly, Jeremy Force, Alvaro Moreno-Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie M. Jones, Jason L. Weirather, Anita Giobbie-Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders

Get full text